Company Filing History:
Years Active: 2007-2014
Title: Ian E Crandall: Innovator in Therapeutic Compounds
Introduction
Ian E Crandall is a notable inventor based in North York, Canada. He has made significant contributions to the field of therapeutic compounds, particularly in the development of new salts and compositions for treating infections and malaria. With a total of 2 patents, his work is recognized for its potential impact on public health.
Latest Patents
Crandall's latest patents include innovative compounds such as triazolium and imidazolium salts. These compounds are designed for therapeutic use, specifically in methods aimed at treating or preventing infections caused by parasites. The disclosure details the specific formulas and therapeutic applications of these salts. Another significant patent focuses on surfactants as agents to reverse malarial resistance to quinolines. This composition includes nonylphenolethoxylate (NPE) and is aimed at enhancing the effectiveness of quinoline-based treatments for malaria.
Career Highlights
Ian E Crandall is affiliated with the University Health Network, where he conducts research and develops his innovative solutions. His work is characterized by a commitment to addressing critical health challenges through scientific advancements.
Collaborations
Crandall has collaborated with notable colleagues, including Walter A Szarek and Jason Z Vlahakis. These partnerships have contributed to the development and refinement of his patented inventions.
Conclusion
Ian E Crandall's contributions to the field of therapeutic compounds highlight his role as an innovator dedicated to improving health outcomes. His patents reflect a commitment to addressing significant medical challenges through innovative solutions.